AJOONI BIOTECH LIMITED
AJOONI · General/Diversified · NSE
₹4
Current Market Price
Fair Value (DCF)
₹3
Discount to FV
-20.7%
Updated just now
YieldIQ Score
40/100
Piotroski F-Score
5/9
Economic Moat
None
Confidence
57%
ROE
3.8%
Debt/Equity
0.02
WACC
11.1%
Market Cap
₹68.04 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
6.4%
Return on capital employed
EV / EBITDA
10.9×
Enterprise multiple
Debt / EBITDA
0.3×
Leverage vs earnings
Interest Coverage
15.4×
EBIT covers interest
Current Ratio
12.86×
Short-term liquidity
Asset Turnover
1.21×
Revenue per ₹ of assets
Revenue CAGR (3Y)
15.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹3.95
Bear case
Discount -81.2%
Base case
Discount -26.2%
Bull case
Discount +9.2%
Ratio Trends
AJOONI · last 5 annual periods
ROE
3.8%
ROCE
6.4%
Operating Margin
—
Debt / Equity
0.02×
PE
60.5×
EV / EBITDA
23.9×
Historical Financials
AJOONI · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 NSE_XBRL | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹51.0 Cr | ₹74.0 Cr | ₹74.5 Cr | ₹80.1 Cr | ₹115 Cr | +22.4% |
| EBITDA | — | ₹3.0 Cr | ₹3.1 Cr | ₹4.4 Cr | ₹5.7 Cr | +17.8% |
| EBIT | ₹1.1 Cr | ₹2.0 Cr | ₹2.1 Cr | ₹3.6 Cr | — | +34.4% |
| PAT | ₹0.4 Cr | ₹1.0 Cr | ₹1.1 Cr | ₹2.2 Cr | ₹3.4 Cr | +73.4% |
| EPS (diluted) | ₹0.37 | ₹1.05 | ₹1.94 | ₹0.25 | — | -9.3% |
| CFO | ₹1.2 Cr | ₹3.7 Cr | ₹-5.6 Cr | ₹22.9 Cr | ₹-17.7 Cr | — |
| CapEx | — | ₹-2.1 Cr | ₹-2.9 Cr | ₹-5.6 Cr | ₹-2.0 Cr | — |
| FCF | — | ₹1.6 Cr | ₹-8.4 Cr | ₹17.3 Cr | ₹-19.8 Cr | — |
| Total Assets | — | ₹29.0 Cr | ₹58.7 Cr | ₹47.5 Cr | ₹95.1 Cr | +34.5% |
| Total Debt | — | ₹5.4 Cr | ₹5.2 Cr | ₹2.2 Cr | ₹1.9 Cr | -22.4% |
| Shareholders' Equity | — | ₹16.4 Cr | ₹41.7 Cr | ₹42.7 Cr | ₹88.1 Cr | +52.3% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
AJOONI vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
ROML ROML | — | — | Pending | — | — |
NGIL NGIL | — | — | Pending | 5.2% | — |
KOHINOOR KOHINOOR | — | — | Pending | — | — |
PALASHSECU PALASHSECU | — | — | Pending | -2.2% | — |
GANGESSECU GANGESSECU | — | — | Pending | 0.5% | 38.7× |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for AJOONI in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. AJOONI BIOTECH LIMITED (AJOONI.NS) trades at 3.95 vs a model fair value of 3.13, a gap of -20.7%. Piotroski F-score: 5/9. Moat label: Non...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of AJOONI →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for AJOONI →
Compare
Head-to-head with peers
Compare AJOONI side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse AJOONINow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.